Name: Microba Life Sciences (MAP) Short Position History
Creator: Shorted
License: https://creativecommons.org/licenses/by/4.0/

MAP

Health Care Equipment & Services

Microba Life Sciences

Short interest: 0.10%; +0.10 pp 30d; as of 19 June 2026
Reported shorts: 700K
Shares on issue: 700.308M

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

About Microba Life Sciences

Microba Life Sciences is a pioneering company in the health care sector, specializing in advanced microbiome analysis technology. Their innovative approach provides deep insights into gut health, enabling precision diagnostics and personalized treatment plans. With a strong focus on scientific rigor and evidence-based solutions, Microba is positioned as a leader in microbiome research and diagnostics.

Company profile →

Microba Life Sciences (ASX:MAP) has 0.10% of its shares on issue reported as short positions as of 19 June 2026, or about 700,000 shares. Over the past 30 days that figure has risen 0.10 percentage points, and over 90 days it has risen 0.10 percentage points. Its highest recorded short interest was 0.97% in June 2025. MAP is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Short interest

History & FAQ →

Weekly context: The 10 most shorted ASX stocks — Week 42, 2026.

Strategy fit

How each stock picker strategy reads MAP today

Zanger BreakoutNot a candidate
CAN SLIMNot a candidate
Minervini Trend TemplateNot a candidate
Crowded-Short BreakoutNot a candidate
Quality compoundersNot a candidate

Prices to 22 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →

MAP fundamentals

In the year to 30 Jun 2026, Microba Life Sciences (ASX:MAP) recorded revenue of A$14.8M and a net loss after tax of A$20.7M. A year earlier it recorded revenue of A$15.7M and a net loss after tax of A$14.9M. Year-on-year growth: revenue −5.8% (FY). Net margin −140.4% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit) and Yahoo Finance, as at 14 Oct 2026.

Full statements, ratios and filings are on the Financials tab. Not financial advice.

Full financials →